🏥 Health
2d ago
New Drug Prevents Worsening Pulmonary Arterial Hypertension in Major Trial Win
Source ↗
👁 1
💬 0
(MedPage Today) -- Oral ralinepag is positioned for potential FDA approval following its strong results as a treatment for pulmonary arterial hypertension (PAH) in an international phase III trial.
In ADVANCE OUTCOMES, ralinepag conferred a reduction...
In ADVANCE OUTCOMES, ralinepag conferred a reduction...
Comments (0)